Document is current
Any future updates will be listed below
-
Authors
Rosar, Florian https://orcid.org/0000-0002-2985-4099
Blickle, Arne
Bastian, Moritz B.
Speicher, Tilman
Schaefer-Schuler, Andrea
Burgard, Caroline
Maus, Stephan
Ezziddin, Samer
-
Funding
Funding for this research was provided by:
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
- License Information
-
More Information
Article History
Received: 15 October 2025
Revised: 28 October 2025
Accepted: 5 November 2025
First Online: 2 December 2025
Declarations
:
: Ethical approval and consent to participate: The study was approved by the institutional review board of Ärztekammer des Saarlandes, Germany (ethics committee approval number 140/17), and informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the Helsinki Declaration as revised in 2013 and its later amendments.
: The participants signed consent regarding publishing their data (and/or photographs).
: Authors did not use generative AI in writing.
: Florian Rosar, Arne Blickle, Moritz B. Bastian, Tilman Speicher, Andrea Schaefer-Schuler, Caroline Burgard, Stephan Maus, and Samer Ezziddin declare that they have no competing interests.
: NCT04833517, Registry: Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study), registration date: 2016–01-01.
